The New England Journal of Medicine | Research & Review Articles …
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
CD19 CAR T-Cell Therapy in Autoimmune Disease - The New …
2024年2月21日 · Treatment for autoimmune diseases such as systemic lupus erythematosus (SLE), idiopathic inflammatory myositis, and systemic sclerosis often involves long-term …
Hydrocortisone in Severe Community-Acquired Pneumonia | New …
2023年3月21日 · New perspectives on community-acquired pneumonia in 388 406 patients: results from a nationwide mandatory performance measurement programme in healthcare …
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH …
2024年2月7日 · From the University of Oxford, Oxford (S.A.H.), the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne …
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type …
2020年10月23日 · Finerenone, a nonsteroidal, selective mineralocorticoid receptor antagonist, reduced albuminuria in short-term trials involving patients with chronic kidney disease (CKD) …
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without ...
2024年6月14日 · Tenecteplase is an effective thrombolytic agent for eligible patients with stroke who are treated within 4.5 hours after the onset of stroke. However, data regarding the …
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell …
2024年9月13日 · Durvalumab is a selective, high-affinity human IgG1 monoclonal antibody that binds to programmed death ligand 1 (PD-L1), blocking its interaction with programmed death 1 …
Medical Articles - The New England Journal of Medicine
Explore the index of articles published by the New England Journal of Medicine, from original research to videos in clinical medicine and more.
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
2024年12月11日 · In a phase 3, open-label trial, we enrolled patients with ER-positive, human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer that recurred or …
Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis
2022年9月14日 · A total of 249 patients were included in the interim analysis. The trial was halted owing to between-group differences in the safety outcomes without a significant difference in …